Ignite Creation Date:
2025-12-24 @ 11:49 PM
Ignite Modification Date:
2026-04-09 @ 11:22 PM
Study NCT ID:
NCT00275951
Status:
COMPLETED
Last Update Posted:
2012-11-16
First Post:
2006-01-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Cetuximab Plus P-HDFL for the First-line Treatment of Advanced Gastric Cancer
Sponsor:
National Taiwan University Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
941004
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None